Combined treatment of portal hypertensio
β
Dr. Gilles Pomier-Layrargues; Lise Giroux; Bernard Rocheleau; Pierre-Michel Huet
π
Article
π
1992
π
John Wiley and Sons
π
English
β 566 KB
We recently reported that ritanserin, a 5-hydroxytryptamine receptor antagonist, induced significant reduction of portal pressure in cirrhotic rats. In this study, we investigated the hemodynamic effects of a combination of propranolol and ritanserin in conscious and unrestrained cirrhotic rats. Hep